Based on the earnings transcript for Merck & Co., Inc., the company reported strong first-quarter results with a 7% increase in sales and a non-GAAP EPS of $0.83. The company's Animal Health division also reported significant growth. The management team highlighted the company's focus on driving revenue growth, maintaining business momentum, and reducing costs. The company also provided guidance for the full year 2010, with a non-GAAP EPS range of $3.27 to $3.41 and a GAAP EPS range of $1.15 to $1.50. The company also discussed its plans for the Animal Health division and the potential for future growth in emerging markets. Overall, the company's results and guidance suggest a positive outlook for the company's stock price in the short term.

Rating: 1